Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
59.27 USD | -2.88% |
|
+2.01% | -14.36% |
07-09 | UBS Adjusts Price Target on Celanese to $66 From $51, Maintains Neutral Rating | MT |
07-03 | RBC Raises Price Target on Celanese to $63 From $53, Keeps Sector Perform Rating | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.5 | 11.16 | 4.95 | 2.72 | 2.75 | |||||
Return on Total Capital | 6.12 | 15.31 | 6.32 | 3.35 | 3.38 | |||||
Return On Equity % | 59 | 45.49 | 35.9 | 28.89 | -22.89 | |||||
Return on Common Equity | 66.2 | 49.57 | 38.71 | 30.94 | -24.69 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 22.86 | 31.42 | 24.6 | 23.79 | 23.61 | |||||
SG&A Margin | 8.21 | 6.17 | 7.13 | 10.46 | 10.21 | |||||
EBITDA Margin % | 19.19 | 28.34 | 20.42 | 16.74 | 17.49 | |||||
EBITA Margin % | 13.32 | 24.2 | 16.22 | 11.61 | 11.72 | |||||
EBIT Margin % | 12.98 | 23.94 | 15.67 | 10.5 | 10.58 | |||||
Income From Continuing Operations Margin % | 35.44 | 22.47 | 19.75 | 18.03 | -14.65 | |||||
Net Income Margin % | 35.1 | 22.14 | 19.58 | 17.92 | -14.81 | |||||
Net Avail. For Common Margin % | 35.31 | 22.4 | 19.66 | 18 | -14.73 | |||||
Normalized Net Income Margin | 9.72 | 16.41 | 9.87 | 4.27 | 4.99 | |||||
Levered Free Cash Flow Margin | 9.31 | 6.53 | -1.56 | 9.84 | 4.96 | |||||
Unlevered Free Cash Flow Margin | 10.52 | 7.2 | 1.06 | 13.95 | 9.07 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.55 | 0.75 | 0.51 | 0.41 | 0.42 | |||||
Fixed Assets Turnover | 1.4 | 1.99 | 1.86 | 1.82 | 1.76 | |||||
Receivables Turnover (Average Receivables) | 6.89 | 8.74 | 7.62 | 8.34 | 8.7 | |||||
Inventory Turnover (Average Inventory) | 4.33 | 4.68 | 3.37 | 3.23 | 3.38 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.91 | 1.52 | 1.63 | 1.53 | 1.34 | |||||
Quick Ratio | 1.38 | 0.88 | 0.88 | 0.88 | 0.67 | |||||
Operating Cash Flow to Current Liabilities | 0.68 | 0.7 | 0.45 | 0.47 | 0.25 | |||||
Days Sales Outstanding (Average Receivables) | 53.14 | 41.75 | 47.92 | 43.74 | 42.08 | |||||
Days Outstanding Inventory (Average Inventory) | 84.58 | 77.99 | 108.4 | 113.06 | 108.15 | |||||
Average Days Payable Outstanding | 67.08 | 55.8 | 56.98 | 70.07 | 64.4 | |||||
Cash Conversion Cycle (Average Days) | 70.63 | 63.94 | 99.34 | 86.73 | 85.83 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 103.93 | 92.66 | 247.76 | 186.68 | 230.91 | |||||
Total Debt / Total Capital | 50.96 | 48.1 | 71.24 | 65.12 | 69.78 | |||||
LT Debt/Equity | 88.19 | 74.41 | 225.01 | 167.19 | 202.75 | |||||
Long-Term Debt / Total Capital | 43.25 | 38.62 | 64.7 | 58.32 | 61.27 | |||||
Total Liabilities / Total Assets | 64.3 | 62.11 | 76.76 | 71.61 | 75.46 | |||||
EBIT / Interest Expense | 6.73 | 22.46 | 3.74 | 1.6 | 1.61 | |||||
EBITDA / Interest Expense | 10.64 | 27.35 | 5.12 | 2.72 | 2.86 | |||||
(EBITDA - Capex) / Interest Expense | 7.3 | 22.22 | 3.78 | 1.94 | 2.21 | |||||
Total Debt / EBITDA | 3.49 | 1.69 | 7.3 | 7.19 | 6.7 | |||||
Net Debt / EBITDA | 2.21 | 1.47 | 6.57 | 6.27 | 6.21 | |||||
Total Debt / (EBITDA - Capex) | 5.09 | 2.08 | 9.89 | 10.11 | 8.65 | |||||
Net Debt / (EBITDA - Capex) | 3.22 | 1.81 | 8.9 | 8.82 | 8.01 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -10.2 | 50.96 | 13.31 | 13.1 | -6.03 | |||||
Gross Profit, 1 Yr. Growth % | -19.49 | 107.42 | -11.26 | 9.37 | -6.76 | |||||
EBITDA, 1 Yr. Growth % | -20.57 | 122.54 | -18.35 | -7.76 | -2.55 | |||||
EBITA, 1 Yr. Growth % | -27.18 | 174.37 | -24.06 | -19.06 | -5.12 | |||||
EBIT, 1 Yr. Growth % | -27.54 | 178.47 | -25.83 | -24.21 | -5.31 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 131.94 | -4.29 | -0.42 | 3.3 | -176.33 | |||||
Net Income, 1 Yr. Growth % | 132.98 | -4.79 | 0.21 | 3.48 | -177.65 | |||||
Normalized Net Income, 1 Yr. Growth % | -25.97 | 154.76 | -31.82 | -51.15 | 9.86 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 144.56 | 1.25 | 2.05 | 3.39 | -177 | |||||
Accounts Receivable, 1 Yr. Growth % | -6.82 | 46.59 | 18.78 | -9.86 | -9.82 | |||||
Inventory, 1 Yr. Growth % | -5.78 | 55.83 | 84.25 | -16.06 | -3.1 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 6.51 | 6.19 | 35.4 | 0.15 | -5.74 | |||||
Total Assets, 1 Yr. Growth % | 15.12 | 9.77 | 119.39 | 1.24 | -14.06 | |||||
Tangible Book Value, 1 Yr. Growth % | 82.07 | 0.05 | -374.73 | -31.18 | -0.21 | |||||
Common Equity, 1 Yr. Growth % | 40.65 | 18.8 | 34.57 | 25.79 | -27.02 | |||||
Cash From Operations, 1 Yr. Growth % | -7.63 | 30.83 | 3.53 | 4.4 | -49.13 | |||||
Capital Expenditures, 1 Yr. Growth % | -1.62 | 28.3 | 16.27 | 4.6 | -23.42 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -29.62 | 5.49 | -127.51 | -865.24 | -53.26 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -27.48 | 2.97 | -83.04 | 1.26K | -39.49 | |||||
Dividend Per Share, 1 Yr. Growth % | 3.33 | 9.68 | 0.74 | 2.19 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -11.1 | 16.44 | 30.79 | 13.2 | 3.09 | |||||
Gross Profit, 2 Yr. CAGR % | -19.03 | 29.23 | 35.67 | -1.48 | 0.98 | |||||
EBITDA, 2 Yr. CAGR % | -17.98 | 32.93 | 34.61 | -13.05 | -5.04 | |||||
EBITA, 2 Yr. CAGR % | -23.72 | 41.15 | 44.06 | -21.65 | -12.61 | |||||
EBIT, 2 Yr. CAGR % | -23.98 | 42.05 | 43.71 | -25.02 | -15.28 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 28.27 | 48.99 | -2.37 | 1.42 | -11.2 | |||||
Net Income, 2 Yr. CAGR % | 28.24 | 48.94 | -2.32 | 1.84 | -10.36 | |||||
Normalized Net Income, 2 Yr. CAGR % | -23.4 | 37.33 | 31.79 | -42.29 | -26.74 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 37.21 | 57.35 | 1.65 | 2.72 | -10.78 | |||||
Accounts Receivable, 2 Yr. CAGR % | -11.75 | 16.87 | 31.95 | 3.47 | -9.84 | |||||
Inventory, 2 Yr. CAGR % | -3.31 | 21.17 | 69.45 | 24.36 | -9.81 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 5.9 | 6.35 | 19.91 | 16.45 | -2.84 | |||||
Total Assets, 2 Yr. CAGR % | 8.23 | 12.42 | 55.19 | 49.03 | -6.73 | |||||
Tangible Book Value, 2 Yr. CAGR % | 12.35 | 34.97 | 65.79 | 37.51 | -17.13 | |||||
Common Equity, 2 Yr. CAGR % | 8.7 | 29.26 | 26.44 | 30.11 | -4.19 | |||||
Cash From Operations, 2 Yr. CAGR % | -7.16 | 9.93 | 16.38 | 3.96 | -27.13 | |||||
Capital Expenditures, 2 Yr. CAGR % | 3.93 | 12.35 | 22.14 | 10.28 | -10.5 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -4.93 | -13.67 | -46.62 | 40.18 | 90.34 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -4.69 | -13.44 | -58.56 | 58.89 | 187.83 | |||||
Dividend Per Share, 2 Yr. CAGR % | 9.19 | 6.46 | 5.11 | 1.46 | 1.09 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -2.71 | 6.06 | 15.38 | 24.6 | 6.39 | |||||
Gross Profit, 3 Yr. CAGR % | -5.06 | 10.79 | 14.01 | 26.27 | -3.28 | |||||
EBITDA, 3 Yr. CAGR % | -5.19 | 14.46 | 12.99 | 18.87 | -9.45 | |||||
EBITA, 3 Yr. CAGR % | -8.66 | 16.88 | 14.8 | 18.88 | -16.49 | |||||
EBIT, 3 Yr. CAGR % | -8.78 | 17.19 | 14.38 | 16.11 | -18.96 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 32.47 | 16.34 | 30.27 | -0.52 | -7.74 | |||||
Net Income, 3 Yr. CAGR % | 33.04 | 16.12 | 30.51 | -0.42 | -6.96 | |||||
Normalized Net Income, 3 Yr. CAGR % | -8.02 | 14.34 | 8.74 | -5.33 | -28.47 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 39.63 | 23.99 | 36.2 | 2.23 | -6.69 | |||||
Accounts Receivable, 3 Yr. CAGR % | -7.04 | 4.51 | 17.5 | 16.21 | -1.16 | |||||
Inventory, 3 Yr. CAGR % | 2.81 | 13.37 | 39.34 | 34.07 | 14.44 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 3.5 | 6 | 15.26 | 12.92 | 8.52 | |||||
Total Assets, 3 Yr. CAGR % | 4.58 | 8.74 | 40.48 | 34.59 | 24.05 | |||||
Tangible Book Value, 3 Yr. CAGR % | 8.84 | 8.09 | 71.05 | 23.68 | 23.57 | |||||
Common Equity, 3 Yr. CAGR % | 6.89 | 11.97 | 31.01 | 26.22 | 7.3 | |||||
Cash From Operations, 3 Yr. CAGR % | 18.7 | 4.09 | 7.75 | 12.24 | -18.08 | |||||
Capital Expenditures, 3 Yr. CAGR % | 10.88 | 11.49 | 13.64 | 15.99 | -2.34 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 1 | -1.45 | -41.39 | 26.74 | -2.38 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 0.65 | -2.09 | -50 | 36.75 | 15.52 | |||||
Dividend Per Share, 3 Yr. CAGR % | 12.54 | 9.35 | 4.52 | 4.13 | 0.97 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -0.07 | 9.64 | 9.52 | 8.86 | 10.3 | |||||
Gross Profit, 5 Yr. CAGR % | -0.38 | 13.8 | 9.51 | 5.71 | 8.61 | |||||
EBITDA, 5 Yr. CAGR % | 0.85 | 15.24 | 9.18 | 2.57 | 5.6 | |||||
EBITA, 5 Yr. CAGR % | 0.54 | 17.82 | 9.69 | -0.37 | 3.05 | |||||
EBIT, 5 Yr. CAGR % | 0.36 | 17.78 | 9.41 | -1.98 | 1.44 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 47.5 | 16.13 | 17.25 | 10.13 | 11.75 | |||||
Net Income, 5 Yr. CAGR % | 45.54 | 16 | 17.57 | 10.18 | 12.3 | |||||
Normalized Net Income, 5 Yr. CAGR % | -0.83 | 16.73 | 6.22 | -13.02 | -7.15 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 53 | 22.48 | 22.98 | 15 | 15 | |||||
Accounts Receivable, 5 Yr. CAGR % | 2.33 | 7.71 | 6.94 | 4.1 | 5.69 | |||||
Inventory, 5 Yr. CAGR % | 7.48 | 16.18 | 25.55 | 17.64 | 17.08 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 2.94 | 4.37 | 9.77 | 10.06 | 7.65 | |||||
Total Assets, 5 Yr. CAGR % | 4.91 | 7.46 | 22.46 | 23.35 | 19.26 | |||||
Tangible Book Value, 5 Yr. CAGR % | 5.69 | 5.03 | 28.79 | 19.01 | 28.01 | |||||
Common Equity, 5 Yr. CAGR % | 8.2 | 10.11 | 14.32 | 18.9 | 15.6 | |||||
Cash From Operations, 5 Yr. CAGR % | 9.27 | 14.49 | 17.77 | 4.04 | -7.85 | |||||
Capital Expenditures, 5 Yr. CAGR % | -6.88 | 13.68 | 15.25 | 11.01 | 3.29 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 28.51 | 3.67 | -21.68 | 13.06 | -7.4 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 22.05 | 2.78 | -29.38 | 18.44 | 2.59 | |||||
Dividend Per Share, 5 Yr. CAGR % | 16.61 | 14.53 | 9.51 | 6.13 | 3.13 |
- Stock Market
- Equities
- CE Stock
- Financials Celanese Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition